Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -601.80K | -514.70K | -1.18M | -991.90K | -803.00K |
| Total Depreciation and Amortization | 98.60K | 95.20K | 41.70K | 35.00K | 36.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 370.80K | 251.00K | 536.00K | 527.90K | 350.80K |
| Change in Net Operating Assets | -58.60K | -140.80K | 600.70K | 235.30K | 224.70K |
| Cash from Operations | -191.00K | -309.30K | 3.20K | -193.70K | -190.80K |
| Capital Expenditure | -- | -- | -4.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 600.00 | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 600.00 | -4.00K | -- | -- |
| Total Debt Issued | 262.00K | 112.00K | -- | -- | 10.90K |
| Total Debt Repaid | -- | -- | -43.70K | -240.10K | -100.00K |
| Issuance of Common Stock | -- | -- | 25.40K | 475.00K | 309.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 377.60K | -- | -- | -- |
| Cash from Financing | 191.00K | 348.30K | -12.80K | 170.70K | 160.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -46.10K | -2.70K | -- | -- | -- |
| Net Change in Cash | -46.10K | 36.80K | -13.50K | -23.00K | -30.20K |